Condition: Metabolic Syndrome (MetS) · Obesity & Overweight · Cardiovascular Diseases (CVD) · Sponsor: Chang Gung Memorial Hospital
This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.
This description comes directly from the study's public registry record.
Chi-Hsiao Yeh, MD PhD · +886-3-3281200 · yehccl@cgmh.org.tw
Always discuss trial participation with your own doctor first.
| Chang Gung Memorial Hospitals, Linkou | Taoyuan, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07248371